In Brief: Synthetic conjugated estrogens ANDAs
Executive Summary
Synthetic conjugated estrogens ANDAs: Hearing requests are due by Sept. 8 regarding the agency's decision to refuse to approve ANDAs from Barr and Duramed. Data and information in support of the hearing request are due by Oct. 6, FDA says in Aug. 7 Federal Register...